NAFLD further results in a hypercoagulatory state with an increased thrombotic risk due to elevated levels of vWF and plasminogen activator inhibitor type I (PAI-1). This evidence concerns the gene SERPINE1 and metabolic dysfunction-associated steatotic liver disease.